Cetera Investment Advisers
RDY icon

Cetera Investment Advisers’s Dr. Reddy's Laboratories RDY Stock Holding History

Cetera Investment Advisers’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,134
Closed -$252K – 4191
2025
Q1 		$252K Sell
19,134
-1,586
-8% -$21.9K ﹤0.01% 3417
2024
Q4 		$327K Buy
20,720
+425
+2% +$6.38K ﹤0.01% 3041
2024
Q3 		$323K Sell
20,295
-300
-1% -$4.83K ﹤0.01% 3001
2024
Q2 		$314K Buy
20,595
+6,505
+46% +$93.2K ﹤0.01% 2992
2024
Q1 		$207K Buy
+14,090
New +$206K ﹤0.01% 3331

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Cetera Investment Advisers's RDY Position: Q2 2025 in Review

Cetera Investment Advisers sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 19,134 shares — an estimated $252K sold.

Cetera Investment Advisers first reported a position in RDY in Q1 2024 and held it in 5 quarters. The position peaked at $327K in Q4 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Cetera Investment Advisers reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 19,134 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $252K.
  • Cetera Investment Advisers first reported a position in Dr. Reddy's Laboratories in Q1 2024 and held it in 5 quarters.
  • Cetera Investment Advisers's Dr. Reddy's Laboratories position peaked at $327K in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Cetera Investment Advisers's 13F filing for Q2 2025, filed 8 Aug 2025.